Accession Therapeutics

Accession Therapeutics is a biotech company in Oxford, United Kingdom, founded in 2021. It has raised $40.0M across 1 round, most recently a $40.0M Venture Round in December 2025.

Immuno-oncology

Headquarters
Oxford
Employees
11–50
Founded
2021
Total Funding
$40.0M
Last Round
$40.0M Venture RoundDec 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Accession Therapeutics develops targeted immuno-oncology treatments using its stealth virus platform, Trocept, to address cancer. Its proprietary pipeline combines highly targeted products with a range of therapeutic payloads. Its first drug candidate is in Phase 1 and recruiting patients in the ATTEST trial, with additional engineered candidates following in development.

Summary

It lists 11–50 employees. It has raised $40.0M in total across 1 round, most recently a $40.0M Venture Round in Dec 2025.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundFunding RoundDec 2025
$40.0M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Accession Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/accession-therapeutics"><img src="https://indexed.vc/api/badge/company/accession-therapeutics" alt="Accession Therapeutics on Indexed.vc" width="260" height="76" /></a>